Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The escalating levels of air pollution have emerged as a significant environmental health hazard, posing a risk factor for both acute and chronic respiratory diseases. According to a comprehensive report by the Forum of International Respiratory Societies (FIRS), various sources contribute to air pollution-related health threats, including tobacco smoke, indoor air pollution from combustion, and pollutants from traffic and industrial activities. The World Health Organization (WHO) estimates that a staggering 4.3 million deaths annually can be linked to indoor air pollution. Notably, the adverse health impacts of prolonged exposure to poor indoor air quality disproportionately affect women and children, particularly in low-income households.
Indoor air pollution, stemming from activities such as burning fuels for heating and cooking, has been identified as a primary contributor to respiratory conditions. WHO highlights that a significant portion of diseases and deaths resulting from extended exposure to suboptimal indoor air quality occurs among women and children, especially those in economically disadvantaged families. Prolonged exposure to indoor smoke used in heating and cooking processes has been linked to conditions such as Chronic Obstructive Pulmonary Disease (COPD), lung cancer, pneumonia, and asthma in children. Given the substantial population affected by respiratory disorders due to air pollution, the demand for cough syrup has witnessed a notable surge, as it plays a pivotal role in the treatment of these respiratory diseases.
The FIRS report underscores the critical role of addressing air pollution as a preventive measure against respiratory illnesses. It emphasizes that mitigation strategies to reduce air pollution can significantly contribute to the reduction of respiratory diseases and associated mortality rates. These measures include stringent regulations on industrial emissions, promoting cleaner energy sources, and raising awareness about the health risks associated with exposure to pollutants.
In the context of the cough syrup market, the rise in respiratory disorders due to air pollution has created a heightened demand for medications that can effectively alleviate symptoms and provide relief to those affected. Cough syrups, being a crucial component of the treatment regimen for respiratory ailments, witness increased utilization in the wake of rising pollution-related health concerns. The prevalence of conditions like COPD, lung cancer, pneumonia, and asthma necessitates effective therapeutic interventions, and cough syrups serve as a frontline treatment to manage these ailments.
As governments, healthcare organizations, and environmental agencies work towards implementing measures to curb air pollution, the cough syrup market continues to play a vital role in addressing the healthcare needs of individuals affected by respiratory disorders. The intersection of environmental health and pharmaceutical interventions underscores the interconnectedness of addressing root causes and providing effective treatments for improved public health outcomes. In conclusion, the surge in respiratory disorders attributable to air pollution has significantly contributed to the growth of the cough syrup market, highlighting the imperative role of these medications in managing and mitigating the impact of environmental health challenges.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Segment Outlook | Type, Distribution Channels, and Region |
Cough Syrup Market Highlights:
Global Cough Syrup Market Overview
Cough Syrup Market Size valued at USD 5.07 Billion in 2023. The Cough Syrup market industry is projected to grow from USD 5.25 Billion in 2024 to USD 6.7 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.09% during the forecast period (2024 - 2032).Increased respiratory diseases and concerns related to self-care, and rising air pollution are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Cough Syrup Market Trends
- Growing respiratory diseases is driving the market growth
Market CAGR for cough syrup is being driven by rising respiratory diseases. The growing number of respiratory diseases have increased the growth of the cough syrup market. The rising geriatric population and enormous air pollution keep boosting market growth. Chronic respiratory diseases like the chronic obstructive pulmonary disease and asthma mainly lead to major variations in morbidity and mortality throughout the different regions. The development and innovations of new and natural cough syrups for kids are being done.
The cough syrups are advised by the doctors or available over-the-counter for patients suffering from sneezing, runny nose, common cold, and other respiratory allergies. The cough syrup ingredients have properties of pro-viral, and according to scientists, they should not be consumed by people infected by the virus. The cough syrups include antihistamines and non-opioids that work on the center of coughs in the brain and stop the histamines that are released naturally, which causes allergies. The cough syrups assist in relieving dry and wet coughs with runny and thick mucus. The growth in geriatric population and the sedentary lifestyles of the population are causing the rise in bad habits like smoking addiction which can lead to respiratory, lung disease, and throat, thus boosting the market. In order to develop cough syrups that are safe for kids and have lesser side effects with ingredients that are natural, advancements and innovations are also being made. The manufacturers are innovating variants fortified with natural herbs and ingredients that have immunity-boosting properties. The increasing expenditure abilities of the consumers and significant growth in the industry of pharmaceutical is expected to boost the market.
The increasing levels of air pollution levels lead to more respiratory diseases, which are the main concern of the governments of different nations, thus boosting the market growth. As per the United Nations Environmental Program report, there are around 7 million premature deaths happening across the world because of air pollution, and almost 99% of the population in the world lives in areas where the air pollution guidelines produced by WHO are not met. Thus, driving the Cough Syrup market revenue.
Cough Syrup Market Segment Insights
Cough Syrup Type Insights
The Cough Syrup market segmentation, based on type, includes Expectorants, Cough Suppressants, Antihistamines, and Combination Medications. The cough suppressants segment dominates the market, accounting for the largest market revenue due to the wide range of awareness and applications for cough syrups as a medication for cough. Cough syrups are predominantly considered for wet and dry coughs, though all of its other benefits are secondary and not known well. It is also the most commonly available dextromethorphan at pharmacies or stores.
Cough Syrup Distribution Channel Insights
The Cough Syrup market segmentation, based on distribution channels, includes Retail Pharmacies, Hospital Pharmacies, ad Online Pharmacies. The retail pharmacies segment dominates the market due to the fact that the common cold and flu or cough are very basic problems, and often people do not choose to go to the doctor when it's not very severe and prolonged. Over-the-counter cough syrups are taken by most of the population which do not require prescriptions. Hence a lot of revenue is made by the retail stores from this market. Furthermore, with the growing awareness among the population, it is anticipated that the online pharmacy segment is going to witness healthy growth.
Figure 1: Cough Syrup Market, by Distribution Channel, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Cough Syrup Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Cough Syrup market dominates the market due to the presence of different significant key market players. The growing cases of respiratory diseases with the availability of treatment for chronic diseases are some of the reasons that are fueling the cough syrup industry's growth in the North American region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: Cough Syrup MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe's Cough Syrup market accounts for the second-largest market share due to the availability of different giant market players and the growth of pharmaceutical industries in this region. Further, the German Cough Syrup market held the largest market share, and the UK Cough Syrup market was the rapid-growing market in the European region.
The Asia-Pacific Cough Syrup Market is expected to grow at the fastest CAGR from 2024 to 2032. This is with the increase in the elderly population, the high prevalence of respiratory disorders, and the prevalence of asthma diseases due to air pollution. Moreover, China’s Cough Syrup market held the largest market share, and the Indian Cough Syrup market was the rapid-growing market in the Asia-Pacific region.
Cough Syrup Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to spread their product lines, which will help the Cough Syrup market grow even more. Market participants are also undertaking a various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Cough Syrup industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Cough Syrup industry to benefit clients and increase the market sector. In recent years, the Cough Syrup industry has offered some of the most significant advantages to medicine. Major players in the Cough Syrup market, including Johnson and Johnson Services, Inc, Zarbee's Natural, Merck & Co. Inc, Pfizer Inc., Procter and Gamble, Reckitt Benckiser Group PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC, Acella Pharmaceuticals LLC, Sanofi, and others, are attempting to increase market demand by investing in research and development operations.
Pfizer Inc., established in 1849, headquartered at The Spiral in Manhattan, New York City, is an American multinational pharmaceutical and biotechnology corporation. The company develops and manufactures medicines and vaccines for oncology, immunology, cardiology, neurology, and endocrinology. The Pfizer-BioNTech Covid-19 vaccine, Nirmatrelvir/ritonavir, a pneumococcal conjugate vaccine, and Palbociclib are the company's largest products by sale. 42% of the company's revenues came from the United States, 8% from Japan, and 50% from other countries, in the year 2022. In December 2016, Pfizer Inc. launched different products to expand its product line under the sub-brand name Corex. Initially launched in 2016, but later, the launch was done in 2017. The state and center regulators have duly proved all the product formulations.
Merck & Co. Inc., headquartered in Rahway, New Jersey, is an American multinational pharmaceutical company. It's one of the largest pharmaceutical companies in the world. They develop and manufacture vaccines, medicine, biological therapies, and animal health products. It has various blockbuster drugs or products, including cancer immunotherapy, vaccines against HPV and chicken pox, and anti-diabetic medication. In February 2019, the research and development facility was expanded by Merck in Billerica, Massachusetts. They invested USD 70 million to develop a robust clinical pipeline, which highlights the requirement to always be up and about in terms of product development and innovation.
Key Companies in the Cough Syrup market include
- Johnson and Johnson Services, Inc
- Zarbee’s Natural
- Merck & Co. Inc
- Pfizer Inc.
- Procter and Gamble
- Reckitt Benckiser Group PLC
- Abott Laboratories
- Novartis AG
- GlaxoSmithKline PLC
- Acella Pharmaceuticals LLC
- Sanofi
Cough Syrup Industry Developments
March 2022:KaraMD announced Pure Health Apple Cider Vinegar Gummies, a vegan gummy aimed to aid ketosis, digestion regulation, weight management, and encourage greater levels of energy.
January 2022:Solace Nutrition, a US-based medical nutrition company, bought R-Kane Nutritionals' assets for an unknown sum. This asset acquisition enables Solace Nutrition to develop synergy between both brands, accelerate growth, and establish a position in an adjacent nutrition sector. R-Kane Nutritionals is a firm established in the United States that specializes in high-protein meal replacement products for weight loss.
February 2021: Johnson and Johnson acquired Zarbee's Naturals; this acquisition helped with demand for natural cough syrups for kids, which also helped Johnson and Johnson to diversify its portfolio.
Cough Syrup Market Segmentation
Cough Syrup Type Outlook
- Expectorants
- Cough Suppressants
- Antihistamines
- Combination Medications
Cough Syrup Distribution Channel Outlook
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Cough Syrup Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
